Immunological Profile of HTLV-1-Infected Patients Associated with Infectious or Autoimmune Dermatological Disorders

PLoS Neglected Tropical Diseases

Volumn 7, Issue 7, 2013, Pages

  Coelho dos Reis, Jordana Grazziela Alves ^a,b,c   Passos, Livia ^a,c   Duarte, Mariana Costa ^a   Araújo, Marcelo Grossi ^c,d   Campi Azevedo, Ana Carolina ^a   Teixeira Carvalho, Andréa ^a   Peruhype Magalhães, Vanessa ^a   Trindade, Bruno Caetano ^a   dos Santos Dias, Raquel ^c,d   Martins, Marina Lobato ^c   Carneiro Proietti, Anna Barbara de Freitas ^c   Guedes, Antônio Carlos ^c,d   Gonçalves, Denise Utsch ^c,d   Martins Filho, Olindo Assis ^a,c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b ROCKEFELLER UNIVERSITY   (United States)

^c Interdisciplinary HTLV Research Group (GIPH)   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTOIMMUNE SKIN DISEASE; BLOOD SAMPLING; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOCYTOCHEMISTRY; IMMUNOLOGICAL PARAMETERS; IMMUNOPHENOTYPING; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NATURAL KILLER T CELL; NONHUMAN; SKIN INFECTION; VIRUS ACTIVATION; VIRUS LOAD; WESTERN BLOTTING;

EID: 84880786314     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002328     Document Type: Article

References (47)

1. Gallo RC, (2005) History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2. Oncogene 24: 5926-5930.
2. Kaplan JE, Osame M, Kubota H, Igata A, Nishitani H, et al. (1990) The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 3: 1096-1101.
3. Popovic M, Sarin PS, Robert-Gurroff M, Kalyanaraman VS, Mann D, et al. (1983) Isolation and transmission of human retrovirus (human t-cell leukemia virus). Science 219: 856-859.
4. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL, (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24: 6058-6068.
5. Sibon D, Gabet AS, Zandecki M, Pinatel C, Thete J, et al. (2006) HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death. J Clin Invest 116: 974-983.
6. Umeki K, Hisada M, Maloney EM, Hanchard B, Okayama A, (2009) Proviral loads and clonal expansion of HTLV-1-infected cells following vertical transmission: a 10-year follow-up of children in Jamaica. Intervirology 52: 115-122.
7. Zane L, Sibon D, Mortreux F, Wattel E, (2009) Clonal expansion of HTLV-1 infected cells depends on the CD4 versus CD8 phenotype. Front Biosci 14: 3935-3941.
8. Bangham CR, Osame M, (2005) Cellular immune response to HTLV-1. Oncogene 24: 6035-6046.
9. Taylor GP, (1998) Pathogenesis and treatment of HTLV-I associated myelopathy. Sex Transm Infect 74: 316-322.
10. Goon PK, Igakura T, Hanon E, Mosley AJ, Asquith B, et al. (2003) High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease. J Virol 77: 9716-9722.
11. Goon PK, Hanon E, Igakura T, Tanaka Y, Weber JN, et al. (2002) High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Blood 99: 3335-3341.
12. Montanheiro PA, Penalva de Oliveira AC, Smid J, Fukumori LM, Olah I, et al. (2009) The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis. Scand J Immunol 70: 403-407.
13. Brito-Melo GE, Peruhype-Magalhaes V, Teixeira-Carvalho A, Barbosa-Stancioli EF, Carneiro-Proietti AB, et al. (2007) IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection. Clin Exp Immunol 147: 35-44.
14. de Oliveira Mde F, Bittencourt AL, Brites C, Soares G, Hermes C, et al. (2004) HTLV-I associated myelopathy/tropical spastic paraparesis in a 7-year-old boy associated with infective dermatitis. J Neurol Sci 222: 35-38.
15. de Oliveira Mde F, Fatal PL, Primo JR, da Silva JL, Batista Eda S, et al. (2012) Infective dermatitis associated with human T-cell lymphotropic virus type 1: evaluation of 42 cases observed in Bahia, Brazil. Clin Infect Dis 54: 1714-1719.
16. Gessain A, Mahieux R, (2012) Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects. Rev Neurol (Paris) 168: 257-269.
17. Amano M, Setoyama M, Grant A, Kerdel FA, (2011) Human T-lymphotropic virus 1 (HTLV-1) infection-dermatological implications. Int J Dermatol 50: 915-920.
18. Bittencourt AL, de Oliveira Mde F, (2010) Cutaneous manifestations associated with HTLV-1 infection. Int J Dermatol 49: 1099-1110.
19. Bittencourt AL, Oliveira Mde F, Brites C, Van Weyenbergh J, da Silva Vieira M, et al. (2005) Histopathological and immunohistochemical studies of infective dermatitis associated with HTLV-I. Eur J Dermatol 15: 26-30.
20. Nascimento MC, Primo J, Bittencourt A, Siqueira I, de Fatima Oliveira M, et al. (2009) Infective dermatitis has similar immunological features to human T lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis. Clin Exp Immunol 156: 455-462.
21. Goncalves DU, Guedes AC, Proietti AB, Martins ML, Proietti FA, et al. (2003) Dermatologic lesions in asymptomatic blood donors seropositive for human T cell lymphotropic virus type-1. Am J Trop Med Hyg 68: 562-565.
22. Brito-Melo GE, Martins-Filho OA, Carneiro-Proietti AB, Catalan-Soares B, Ribas JG, et al. (2002) Phenotypic study of peripheral blood leucocytes in HTLV-I-infected individuals from Minas Gerais, Brazil. Scand J Immunol 55: 621-628.
23. Peruhype-Magalhaes V, Martins-Filho OA, Prata A, Silva Lde A, Rabello A, et al. (2006) Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection. Clin Exp Immunol 146: 124-132.
24. Furtado Mdos S, Andrade RG, Romanelli LC, Ribeiro MA, Ribas JG, et al. (2012) Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease. J Med Virol 84: 664-671.
25. Farre L, de Oliveira Mde F, Primo J, Vandamme AM, Van Weyenbergh J, et al. (2008) Early sequential development of infective dermatitis, human T cell lymphotropic virus type 1-associated myelopathy, and adult T cell leukemia/lymphoma. Clin Infect Dis 46: 440-442.
26. La Grenade L, Manns A, Fletcher V, Derm D, Carberry C, et al. (1998) Clinical, pathologic, and immunologic features of human T-lymphotrophic virus type I-associated infective dermatitis in children. Arch Dermatol 134: 439-444.
27. Primo JR, Brites C, Oliveira Mde F, Moreno-Carvalho O, Machado M, et al. (2005) Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence. Clin Infect Dis 41: 535-541.
28. Pancake BA, Zucker-Franklin D, Coutavas EE, (1995) The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients. J Clin Invest 95: 547-554.
29. Hall WW, Liu CR, Schneewind O, Takahashi H, Kaplan MH, et al. (1991) Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides. Science 253: 317-320.
30. Khan ZM, Sebenik M, Zucker-Franklin D, (1996) Localization of human T-cell lymphotropic virus-1 tax proviral sequences in skin biopsies of patients with mycosis fungoides by in situ polymerase chain reaction. J Invest Dermatol 106: 667-672.
31. Pancake BA, Zucker-Franklin D, (1993) HTLV tax and mycosis fungoides. N Engl J Med 329: 580.
32. Zucker-Franklin D, Kosann MK, Pancake BA, Ramsay DL, Soter NA, (1999) Hypopigmented mycosis fungoides associated with human T cell lymphotropic virus type I tax in a pediatric patient. Pediatrics 103: 1039-1045.
33. Zucker-Franklin D, Pancake BA, Najfeld V, (2003) Localization of HTLV-I tax proviral DNA in mononuclear cells. Blood Cells Mol Dis 31: 1-6.
34. Bazarbachi A, Soriano V, Pawson R, Vallejo A, Moudgil T, et al. (1997) Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study. Br J Haematol 98: 927-933.
35. Bazarbachi A, Saal F, Laroche L, Flageul B, Peries J, et al. (1993) HTLV-1 provirus and mycosis fungoides. Science 259: 1470-1471.
36. Fouchard N, Mahe A, Huerre M, Fraitag S, Valensi F, et al. (1998) Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases. Leukemia 12: 578-585.
37. Whittaker SJ, Luzzatto L, (1993) HTLV-1 provirus and mycosis fungoides. Science 259: 1470 author reply 1471.
38. Bonin S, Tothova SM, Barbazza R, Brunetti D, Stanta G, et al. (2010) Evidence of multiple infectious agents in mycosis fungoides lesions. Exp Mol Pathol 89: 46-50.
39. Coelho-dos-Reis JG, Rocha RD, Brito-Melo GE, Ribas JG, Carneiro-Proietti AB, et al. (2007) [Evaluation of the performance of immunological parameters as indicators for clinical progression of chronic HTLV-1 infection]. Rev Soc Bras Med Trop 40: 29-36.
40. Guerreiro JB, Santos SB, Morgan DJ, Porto AF, Muniz AL, et al. (2006) Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state. Clin Exp Immunol 145: 296-301.
41. Baba M, Imai T, Yoshida T, Yoshie O, (1996) Constitutive expression of various chemokine genes in human T-cell lines infected with human T-cell leukemia virus type 1: role of the viral transactivator Tax. Int J Cancer 66: 124-129.
42. Barrios CS, Abuerreish M, Lairmore MD, Castillo L, Giam CZ, et al. (2011) Recombinant human T-cell leukemia virus types 1 and 2 Tax proteins induce high levels of CC-chemokines and downregulate CCR5 in human peripheral blood mononuclear cells. Viral Immunol 24: 429-439.
43. Bezerra CA, Cardoso TM, Giudice A, Porto AF, Santos SB, et al. (2011) Evaluation of the microbicidal activity and cytokines/chemokines profile released by neutrophils from HTLV-1-infected individuals. Scand J Immunol 74: 310-317.
44. Rahman S, Khan ZK, Wigdahl B, Jennings SR, Tangy F, et al. (2011) Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection. J Immunol 186: 390-402.
45. Toulza F, Nosaka K, Tanaka Y, Schioppa T, Balkwill F, et al. (2010) Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells. J Immunol 185: 183-189.
46. Inagaki S, Takahashi M, Fukunaga Y, Takahashi H, (2012) HTLV-I-infected breast milk macrophages inhibit monocyte differentiation to dendritic cells. Viral Immunol 25: 106-116.
47. Nascimento CR, Lima MA, de Andrada Serpa MJ, Espindola O, Leite AC, et al. (2011) Monocytes from HTLV-1-infected patients are unable to fully mature into dendritic cells. Blood 117: 489-499.